Stifel Nicolaus sets a price target of $80 for Alcon Inc. (NYSE:ALC), slightly below its current trading price.Alcon's planned acquisition of STAAR Surgical is terminated due to failure in securing necessary stockholder votes.STAAR Surgical remains optimistic about its future, focusing on profitable sales growth and global expansion of its EVO ICL technology.Alcon Inc. (NYSE:ALC) is a prominent player in the ophthalmic industry, specializing in eye care products and surgical equipment. The company is known ...